Advancing synthetic immunology

Senti Biosciences

This clinical-stage biotechnology company develops programmable cell and gene therapies using synthetic biology and gene circuits to treat patients with cancer and incurable diseases.

Cell Design Labs

This biotherapeutics company develops programmable cell therapies for cancer patients by engineering immune cells with synthetic genetic circuits to improve precision and safety.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

SynsoryBio

SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.

Synthekine

This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.

Synteny Biotechnology

The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.